These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Diffuse midline glioma with H3 K27M-mutation in an 83-year-old woman. Low JT; Wang SH; B Peters K CNS Oncol; 2021 Jun; 10(2):CNS71. PubMed ID: 33908265 [TBL] [Abstract][Full Text] [Related]
10. MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered. Zhao JP; Liu XJ; Lin HZ; Cui CX; Yue YJ; Gao S; Xu HZ BMC Neurol; 2022 Dec; 22(1):498. PubMed ID: 36550486 [TBL] [Abstract][Full Text] [Related]
11. Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. Odia Y; Hall MD; Cloughesy TF; Wen PY; Arrillaga-Romany I; Daghistani D; Mehta MP; Tarapore RS; Ramage SC; Allen JE Neuro Oncol; 2024 May; 26(Supplement_2):S165-S172. PubMed ID: 38386699 [TBL] [Abstract][Full Text] [Related]
12. A Rare High-Grade Glioma with a Histone H3 K27M Mutation in the Hypothalamus of an Adult Patient. He P; Chen W; Qiu XX; Xi YB; Guan H; Xia J World Neurosurg; 2019 Aug; 128():527-531. PubMed ID: 31048046 [TBL] [Abstract][Full Text] [Related]
13. Diffuse midline glioma H3K27M mutation in adult: A case report. Bhattarai AM; Mainali G; Jha P; Karki P; Adhikari A; Pandit A; Bhattarai AM Ann Med Surg (Lond); 2022 Apr; 76():103567. PubMed ID: 35495373 [TBL] [Abstract][Full Text] [Related]
14. Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort. Hayashi N; Fukai J; Nakatogawa H; Kawaji H; Yoshioka E; Kodama Y; Nakajo K; Uda T; Naito K; Kijima N; Okita Y; Kagawa N; Takahashi Y; Hashimoto N; Arita H; Takano K; Sakamoto D; Iida T; Arakawa Y; Kawauchi T; Sonoda Y; Mitobe Y; Ishibashi K; Matsuda M; Achiha T; Tomita T; Nonaka M; Hara K; Takebe N; Tsuzuki T; Nakajima Y; Ohue S; Nakajima N; Watanabe A; Inoue A; Umegaki M; Kanematsu D; Katsuma A; Sumida M; Shofuda T; Mano M; Kinoshita M; Mori K; Nakao N; Kanemura Y Acta Neuropathol Commun; 2024 Jul; 12(1):120. PubMed ID: 39061104 [TBL] [Abstract][Full Text] [Related]
15. Diffuse midline glioma H3 K27M-mutant in adults: A report of six cases and literature review. Alzoubi H; Maraqa B; Hasasna N; Giangaspero F; Antonelli M; Gianno F; Arcella A; Al-Hussaini M Clin Neuropathol; 2021; 40(2):108-117. PubMed ID: 33191898 [TBL] [Abstract][Full Text] [Related]
16. A case of diffuse midline glioma, H3 K27M mutant mimicking a hemispheric malignant glioma in an elderly patient. Fujioka Y; Hata N; Hatae R; Suzuki SO; Sangatsuda Y; Nakahara Y; Mizoguchi M; Iihara K Neuropathology; 2020 Feb; 40(1):99-103. PubMed ID: 31762138 [TBL] [Abstract][Full Text] [Related]
17. H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review. Al Sharie S; Talafha M; Abu Laban D; Al Awabdeh T; Al-Mousa A; Al-Masri N; Al-Hussaini M Clin Neuropathol; 2022; 41(6):263-270. PubMed ID: 35770519 [TBL] [Abstract][Full Text] [Related]
18. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101 [TBL] [Abstract][Full Text] [Related]
19. Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient. Cheng R; Li DP; Zhang N; Zhang JY; Zhang D; Liu TT; Yang J; Ge M Front Surg; 2021; 8():616334. PubMed ID: 34222313 [No Abstract] [Full Text] [Related]